RIWI Corp.

RIWI Corp.

June 14, 2016 19:29 ET

RIWI Announces Appointment of Dr. Ken Adelman, Former U.S. Arms Control Director and UN Ambassador, to RIWI's Board of Directors, and Announces Grant of Stock Options

TORONTO, ONTARIO--(Marketwired - June 14, 2016) - RIWI Corp. (CSE:RIW) (the "Company" or "RIWI") is pleased to announce the appointment of Dr. Ken Adelman, former U.S. Ambassador to the United Nations and Arms Control Director for President Ronald Reagan, to RIWI's Board of Directors.

"Dr. Adelman's credentials and experience align perfectly with the direction and growth of the Company," said Neil Seeman, RIWI's Chairman and Chief Executive Officer. Dr. Adelman began working for the U.S. government in 1969 at the U.S. Department of Commerce, and then served in the Office of Economic Opportunity. From 1975 to 1977, he was an Assistant to U.S. Secretary of Defense Donald Rumsfeld during President Gerald Ford's Administration. Dr. Adelman became a Deputy U.S. Ambassador to the United Nations and then Arms Control Director for President Reagan. He served on the Defense Policy Board during President George W. Bush's Administration and the Board of the National Center for Counter-Terrorism during President Barack Obama's Administration.

"Our clients need a factual understanding of what citizens truly think on sensitive issues - such as changing attitudes toward oppressive regimes, or toward abrupt policy changes in all parts of China, Africa, Russia or the Middle East," said Mr. Seeman. "In Ambassador Adelman, we are privileged to have an internationally acclaimed expert who has worked on the most complex issues in world history, such as nuclear disarmament, where reliable opinion data in hard-to-reach regions of the world is essential."

Dr. Adelman has served on the board of Trustees of Freedom House, was a translator for the late Muhammad Ali during "The Rumble in the Jungle" in Africa, was a professor of Shakespeare at Georgetown University, and author of six books, most recently, Reagan at Reykjavik: Forty-Eight Hours that Ended the Cold War.

RIWI further announces that, subject to regulatory approval, it has granted an aggregate of 232,500 stock options ("Options") to certain directors and officers Company pursuant to the Company's stock option plan. The Options expire on June 14, 2021, and are exercisable at a price of $2.14 per share.

About RIWI

RIWI is a global survey technology that captures citizen and consumer opinion in any country in the world, using its proprietary, patented methods. For more information, please visit: https://riwi.com/.


Neil Seeman, CEO


All statements contained in this news release, except for statements of historical fact, that address activities, events or developments the Company expects or anticipates will or may occur in the future is considered "forward looking information" within the meaning of applicable securities laws. These statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward looking statements in this news release (express or implied) include, but are not limited to, anticipated business and financial growth of the Company, and expectations regarding the use and validity of the Company's products for future applications. There can be no assurance that such forward looking statements will prove to be accurate, as actual results and future events could vary or differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. More detailed information about potential factors that could affect projected results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company.

Contact Information